Biotech · Private company
Clarametyx Biosciences, Inc.
Track this companyFree. Adds Clarametyx Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- CMTX-101Phase 2 · Persistent InfectionClinicalTrials.gov · fetched Nov 12, 2026
- CMTX-101Phase 1 · Community-acquired PneumoniaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study To Evaluate The Safety Of CMTX-101 In People With Cystic FibrosisPHASE1_PHASE2 · COMPLETED · started Jun 24, 2024ClinicalTrials.gov NCT06159725 · fetched Nov 12, 2026
- A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101PHASE1 · TERMINATED · started Nov 14, 2022ClinicalTrials.gov NCT05629741 · fetched Nov 12, 2026